CSIMarket
 
T2 Biosystems Inc   (TTOO)
Other Ticker:  
 
 


 
 TTOO $4.1800 $0.1600 3.98%

 Volume (M): 71   Open : 3.98    52 Wk Avg :  17.18

 
 TTOO $4.1800 $0.1600 3.98%

 Volume (M): 71   Open : 3.98    52 Wk Avg :  17.18




TTOO Today's High: $4.24 TTOO Shares One Week Perf: -6.49 %
TTOO Today's Low: $ 3.98 TTOO Shares 30 Day Performance: -32.91 %
Number of TTOO Shares Traded (M): 71 TTOO Share Price 52 Wk High: $ 70.00
Value of TTOO's Shares Traded (M$): $ 298 TTOO Share Price 52 Wk Avg: $17.18
Share Price at the Open: $3.98 TTOO's Share Price 52 Wk Low: $3.36



  News about T2 Biosystems Inc's Stock Splits and Dividends

T2 Biosystems Inc. Announces Split-Adjusted Basis for Common Stock Trading in Efforts to Benefit Shareholders


T2 Biosystems Inc. (T2), a leading developer of innovative diagnostic tools, recently made a significant announcement regarding the trading of its common stock. Effective October 13, 2023, the company's common stock is expected to begin trading on a split-adjusted basis. This strategic move by T2 aims to impact its shareholders positively and reflect improved market conditions.
The decision to trade on a split-adjusted basis indicates that T2 Biosystems will split its existing shares to provide shareholders with additional shares. This adjustment will not significantly alter the total value of the company, but it will increase the total number of outstanding shares. Ultimately, this action aims to enhance the liquidity and attractiveness of T2 Biosystems' shares to investors in the market.

T2 Biosystems Announces Inducement Awards for New Employees, Reflecting Company's Commitment to Combating Sepsis



LEXINGTON, Mass., Sept. 15, 2023 - T2 Biosystems, Inc. (NASDAQ:TTOO), a pioneer in the rapid detection of sepsis-causing pathogens, has recently announced the issuance of inducement awards to four new employees. This move reflects the company's ongoing dedication to combating sepsis, a life-threatening condition that affects millions of people worldwide. While T2 Biosystems has faced challenges with its stock performance this year, this news signifies a positive step forward for the company.
The Impact on Shareholders:
T2 Biosystems' decision to issue inducement awards to new employees demonstrates its confidence in the strength and potential of its team. By investing in talented individuals, the company aims to strengthen its capabilities in detecting sepsis-causing pathogens, ultimately benefiting shareholders. As the new employees bring fresh perspectives and skills to the table, they could contribute to the development of innovative solutions, potentially leading to increased market share and revenue growth for T2 Biosystems.





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com